Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole Bouchard

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Molecular Cancer Therapeutics|June 28, 2019
Analysis of the Genomic Landscape in ALK+ NSCLC Patients Identifies Novel Aberrations Associated with Clinical OutcomesMathilde Couëtoux du Tertre, Maud Marques, Lise Tremblay, et al.
Frontiers in Oncology|August 7, 2023
Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors' response in non-small cell lung cancer: a multicenter cohort studyMarion Tonneau, Kim Phan, Venkata S K Manem, et al.
Clinical Proteomics|February 15, 2020
Discovery of a putative blood-based protein signature associated with response to ALK tyrosine kinase inhibitionMathilde Couëtoux du Tertre, Maud Marques, Suzan McNamara, et al.
Nature Medicine|February 4, 2022
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancerLisa Derosa, Bertrand Routy, Andrew Maltez Thomas, et al.
Cell|June 21, 2024
Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcomeLisa Derosa, Valerio Iebba, Carolina Alves Costa Silva, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Molecular Cancer Therapeutics|June 28, 2019
Analysis of the Genomic Landscape in ALK+ NSCLC Patients Identifies Novel Aberrations Associated with Clinical OutcomesMathilde Couëtoux du Tertre, Maud Marques, Lise Tremblay, et al.
Frontiers in Oncology|August 7, 2023
Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors' response in non-small cell lung cancer: a multicenter cohort studyMarion Tonneau, Kim Phan, Venkata S K Manem, et al.
Clinical Proteomics|February 15, 2020
Discovery of a putative blood-based protein signature associated with response to ALK tyrosine kinase inhibitionMathilde Couëtoux du Tertre, Maud Marques, Suzan McNamara, et al.
Nature Medicine|February 4, 2022
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancerLisa Derosa, Bertrand Routy, Andrew Maltez Thomas, et al.
Cell|June 21, 2024
Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcomeLisa Derosa, Valerio Iebba, Carolina Alves Costa Silva, et al.
Pageof 2